First Manhattan’s CalciMedica CALC Stock Holding History

First Manhattan’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,645	Closed	-$7.14K	–	754
2026 Q1	$7.14K	Hold	2,645	–	–	﹤0.01%	753
2025 Q4	$87.2K	Hold	2,645	–	–	﹤0.01%	717
2025 Q3	$40.7K	Hold	2,645	–	–	﹤0.01%	711
2025 Q2	$21.2K	Hold	2,645	–	–	﹤0.01%	695
2025 Q1	$25.3K	Buy	+2,645	New	+$33K	﹤0.01%	673
2024 Q4	–	Sell	-2,645	Closed	-$58.6K	–	685
2024 Q3	$58.6K	Hold	2,645	–	–	﹤0.01%	673
2024 Q2	$52.4K	Hold	2,645	–	–	﹤0.01%	657
2024 Q1	$55K	Hold	2,645	–	–	﹤0.01%	866
2023 Q4	$37.8K	Hold	2,645	–	–	﹤0.01%	921
2023 Q3	$35.2K	Hold	2,645	–	–	﹤0.01%	941
2023 Q2	$53K	Buy	+2,645	New	+$57.8K	﹤0.01%	880
2023 Q1	–	Sell	-3,876	Closed	-$136K	–	1550
2022 Q4	$136K	Sell	3,876 -295	-7%	-$16.5K	﹤0.01%	775
2022 Q3	$274K	Hold	4,171	–	–	﹤0.01%	630
2022 Q2	$318K	Hold	4,171	–	–	﹤0.01%	619
2022 Q1	$359K	Hold	4,171	–	–	﹤0.01%	645
2021 Q4	$534K	Hold	4,171	–	–	﹤0.01%	556
2021 Q3	$969K	Hold	4,171	–	–	﹤0.01%	431
2021 Q2	$1.58M	Buy	+4,171	New	+$1.37M	0.01%	366

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Manhattan's CALC Position: Q2 2026 in Review

First Manhattan sold out of CalciMedica (CALC) in Q2 2026, closing a stake of 2,645 shares — an estimated $7.14K sold.

First Manhattan first reported a position in CALC in Q2 2021 and held it in 18 quarters. The position peaked at $1.58M in Q2 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

First Manhattan reported no remaining CalciMedica position as of Q2 2026 after selling out during the quarter.
First Manhattan sold 2,645 CalciMedica shares in Q2 2026, an estimated $7.14K.
First Manhattan first reported a position in CalciMedica in Q2 2021 and held it in 18 quarters.
First Manhattan's CalciMedica position peaked at $1.58M in Q2 2021.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on First Manhattan's 13F filing for Q2 2026, filed 14 Aug 2026.